Join
Live feed
·
PRReleasevia Quantisnow
iSpecimen Inc. logo

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

ByQuantisnow·Wall Street's wire, on your screen.
ISPC· iSpecimen Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ISPC (iSpecimen Inc.) and more on Quantisnow.